Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3 ‐Driven Inflammation and Gouty Arthritis

ConclusionOur results present β‐carotene as a selective and direct inhibitor of NLRP 3, and the binding of β‐carotene to NLRP 3 PYD as a novel pharmacologic strategy to combat NLRP 3 inflammasome–driven diseases, including gouty arthritis.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Tags: Original Article Source Type: research
More News: Arthritis | Gout | Rheumatology | Study